Antiviral responses induced by Tdap-IPV vaccination are associated with persistent humoral immunity to Bordetella pertussis.
Saved in:
| Title: | Antiviral responses induced by Tdap-IPV vaccination are associated with persistent humoral immunity to Bordetella pertussis. |
|---|---|
| Authors: | Gillard J; Laboratory of Medical Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.; Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, CA, USA., Suffiotti M; Service of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland., Brazda P; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands., Venkatasubramanian PB; Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, The Netherlands., Versteegen P; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands., de Jonge MI; Laboratory of Medical Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.; Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands., Kelly D; Department of Paediatrics, Oxford Vaccine Group, University of Oxford, Oxford, UK.; Oxford NIHR Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Bibi S; Department of Paediatrics, Oxford Vaccine Group, University of Oxford, Oxford, UK.; Oxford NIHR Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Pinto MV; Department of Paediatrics, Oxford Vaccine Group, University of Oxford, Oxford, UK.; Oxford NIHR Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.; Egas Moniz Center for Interdisciplinary Research (CiiEM), Egas Moniz School of Health & Science, Caparica, Almada, Portugal., Simonetti E; Laboratory of Medical Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.; Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands., Babiceanu M; Sanofi Pasteur VaxDesign, Orlando, FL, USA., Kettring A; Sanofi Pasteur VaxDesign, Orlando, FL, USA., Teodosio C; Leiden University Medical Center, Immunohematology & Blood Transfusion, Leiden, The Netherlands., de Groot R; Laboratory of Medical Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.; Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands., Berbers G; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands., Stunnenberg HG; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Schanen B; Sanofi Pasteur VaxDesign, Orlando, FL, USA., Fenwick C; Service of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland., Huynen MA; Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, The Netherlands., Diavatopoulos DA; Laboratory of Medical Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, The Netherlands. dimitri.diavatopoulos@radboudumc.nl.; Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, The Netherlands. dimitri.diavatopoulos@radboudumc.nl. |
| Source: | Nature communications [Nat Commun] 2024 Mar 08; Vol. 15 (1), pp. 2133. Date of Electronic Publication: 2024 Mar 08. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2041-1723 |
|---|---|
| DOI: | 10.1038/s41467-024-46560-w |
